Biote Stock Quote BTMD - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Biote Corporation (BTMD) Quote

Biote Corporation (BTMD)

5.52

-0.06

(-1.08%)

Closed April 26 4:00PM

Delayed by 15 minutes

5.52

0.00

( 0.00% )

Pre Market: 7:00AM

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

5.52

Bid

5.12

Ask

5.86

Volume

-

0.00 Day's Range 0.00

3.6538 52 Week Range 8.22

Market Cap

Previous Close

5.52

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

119,409

Shares Outstanding

72,759,419

Dividend Yield

-

PE Ratio

121.05

Earnings Per Share (EPS)

0.05

Revenue

185.36M

Net Profit

3.32M

Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business.

Sector

Medicinal Chems,botanicl Pds

Industry

Medicinal Chems,botanicl Pds

Website

www.biote.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Biote Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker BTMD. The last closing price for Biote was $5.52. Over the last year, Biote shares have traded in a share price range of $ 3.6538 to $ 8.22.

Biote currently has 72,759,419 shares outstanding. The market capitalization of Biote is $401.63 million. Biote has a price to earnings ratio (PE ratio) of 121.05.

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

Grew practitioner network to over 7,100 from 6,400 in 2022 Launched BioteRx, our new hormone and therapeutic wellness offerings Enhancing shareholder value with agreement to repurchase 18.4M...

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares

Company to repurchase approximately 18.4 million Class A shares and Paired Interests at $4.17 per share biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in...

Biote Announces $20 Million Share Repurchase Authorization

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote to Purchase Asteria Health

Strategic and accretive transaction enables vertical integration of hormone product manufacturing biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive...

Biote Names Robert Peterson as Chief Financial Officer

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports Third Quarter 2023 Financial Results

Achieves Progress in Test of Complementary Wellness Therapeutics Reiterates 2023 Financial Guidance Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the...

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

Grew practitioner network to over 7,100 from 6,400 in 2022 Launched BioteRx, our new hormone and therapeutic wellness offerings Enhancing shareholder value with agreement to repurchase 18.4M...

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares

Company to repurchase approximately 18.4 million Class A shares and Paired Interests at $4.17 per share biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in...

Biote Announces $20 Million Share Repurchase Authorization

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote to Purchase Asteria Health

Strategic and accretive transaction enables vertical integration of hormone product manufacturing biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive...

Biote Names Robert Peterson as Chief Financial Officer

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports Third Quarter 2023 Financial Results

Achieves Progress in Test of Complementary Wellness Therapeutics Reiterates 2023 Financial Guidance Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-1.42857142857	5.6	5.8	5.4	49895	5.55447538	CS
4	-0.34	-5.80204778157	5.86	6.22	5.3	91459	5.79006833	CS
12	1.57	39.746835443	3.95	7.5	3.9001	119409	5.66335943	CS
26	0.34	6.56370656371	5.18	7.5	3.6538	104966	5.2634992	CS
52	-0.96	-14.8148148148	6.48	8.22	3.6538	120039	5.62680484	CS
156	-4.52	-45.0199203187	10.04	10.51	2.75	106892	5.25732519	CS
260	-4.52	-45.0199203187	10.04	10.51	2.75	106892	5.25732519	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCPHDeciphera Pharmaceuticals Inc	$ 25.095 (71.30%)	560.67k
INHDInno Holdings Inc	$ 0.893 (41.63%)	8.65M
CSPICSP Inc	$ 18.46 (36.44%)	13
SRZNSurrozen Inc	$ 12.00 (33.63%)	11
ARQQArqit Quantum Inc	$ 0.6388 (30.98%)	6.32M
CLVRClever Leaves Holdings Inc	$ 1.64 (-60.10%)	83.34k
MRXMarex Group PLC	$ 7.60 (-60.00%)	1.02k
ADXNAddex Therapeutics Ltd	$ 7.28 (-54.78%)	12.24k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 31.09 (-20.83%)	511.67k
TSDDGraniteShares ETF Trust GraniteShares	$ 19.75 (-20.68%)	85.8k
AKANAkanda Corporation	$ 0.1312 (27.38%)	14.66M
INHDInno Holdings Inc	$ 0.8972 (42.30%)	8.65M
PEGYPineapple Energy Inc	$ 0.0654 (4.47%)	7.25M
ARQQArqit Quantum Inc	$ 0.6353 (30.26%)	6.33M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 8.64 (20.84%)	5.76M

al44

al44 3 minutes ago

Bet on it-

https://i0.wp.com/politicallyincorrecthumor.com/wp-content/uploads/2024/04/superwealthy-totalitarian-warmonger-not-best-interests-at-heart.jpg?w=520&ssl=1

Volcano

Volcano 4 minutes ago

NKGN

Huge news just out

Mark

Mark 5 minutes ago

$BIVI .54 on 13m funding news

al44

al44 6 minutes ago

Monday's Energy Absurdity: Cornell Launches 'Respiration Chamber' to Measure Cow Burps and Farts

University officials assure us it is the 'gold standard' of fart chambers
David Blackmon
Apr 29, 2024
https://substackcdn.com/image/fetch/w_1272,c_limit,f_webp,q_auto:

timberwolf7

timberwolf7 7 minutes ago

So which die hard commie supporter with their TDS is going to be missing from here this morning??

https://www.thegatewaypundit.com/2024/04/63-year-old-new-york-leftist-tds-arrested/

EXCLUSIVE: Unhinged 63-Year-Old New York Leftist with TDS Gets Rude Awakening – Is Arr

ShadowIllusionist85

ShadowIllusionist85 7 minutes ago

Good thing you’re used to being let down by this company.

SunshineSmiles

SunshineSmiles 8 minutes ago

SHIB needs to start performing like a show dog and stop acting like a junkyard dog.

Sheesh LOLZ

timberwolf7

timberwolf7 8 minutes ago

ah, so to YOU, an unborn baby is a 'nothing'? Says volumes about you. Not to mention the 'emotionally charged' BS reasons used to

JUSTIFY MURDERING an unborn baby. Cause there is very little justification for it being NECESSARY other than to save a mothers life.

A

SidewaysTrader

SidewaysTrader 8 minutes ago

Todays 4 a re nearly like last weeks with $NIVF the new call, hitting scanners. $JAGX is showing strength and moving up again. $TLIF needs to break .014 soon and $WONDF continues to climb back up and looks bullish. $NSAV is on fire also

netmoney1999

netmoney1999 9 minutes ago

Last day for this stale moldy fortune cookie?

OTC should've slapped a CE flag on this one back when they tried pretending to not be a shell and moving money around with SmartShow.

BigBang

BigBang 9 minutes ago

Livin the good lifeThere has to be more to life than the material things you own such as a Ferrari! Must be a shallow and meaningless existence if that is the case. Many with extreme wealth and possessions have been known to commit suicide.

Sweetleaf

Sweetleaf 10 minutes ago

Yes it is under $2.00. Are you saying it is a bargain under $2.00?

Please advise.. thank you

AtlasQ

AtlasQ 11 minutes ago

I wasn’t sure about that, if it ends up a flat day, will be happy. (Unless some news comes out) Now that the demand is increasing, MMs can manipulate to their liking. Godspeed to all of us.

Just some wild daydreams here, Biden promised to come up with cure for cancer a while back an

Stinger2014

Stinger2014 11 minutes ago

IMO this recent drop has priced in a RS. With miners doing their thing, we wait for Logan. MC is ridicules.

HD2001

HD2001 12 minutes ago

By the way the dilution doesn't bother me it's the many lies xalles tells shareholders.

BullNBear52

BullNBear52 12 minutes ago

~~COMPX 4/29/2024~~~~~~~

Previous Close

15,927.90 +316.14

16042 BullNBear52
15799 SSKILLZ1

nelson1234

nelson1234 12 minutes ago

Hweb, Larry, IMMR the Singer family.. could you tell me a few things they have done that were shareholder unfriendly with stocks they controlled?

On IMMR, I just started looking at them, and I'm still not sure what the do or how they make money.

best.

Spuds McKenz66

Spuds McKenz66 12 minutes ago

let it be , merry men SQQQ

Dj56

Dj56 13 minutes ago

Have any of you experienced investors ever had an intuitive feeling something big was about to take place...like a big increase in sp and it did...every time...

If so does AFFU sp big increase loom really soon in your intuitive visioning or is it always simply a risk/reward evaluation

valuemind

valuemind 13 minutes ago

SMCI down 1+% pre-market, possibly a healthy breath before back over 900 as earning is coming in tomorrow.

PoeseidonXXX

PoeseidonXXX 14 minutes ago

Dragon Lady

Dragon Lady 14 minutes ago

ALERT: $INND INNER-CON LOSES PINK CURRENT OTC !!!

$INND Innerscope Hearing Technologies moved to YIELD SIGN aka PINK LIMITED tier - there's a reason this POS crime scene couldn't get anyone to pen a POS 2-bit scam "Attorney ltr" folks.....

Too broke to afford some gu

StockRocket

StockRocket 15 minutes ago

Back to lying Laster...you really are laughable...And no if you didn't load prior to trading stop, you're going to pay for shares dearly now. The dilution for Diagonal is over and was only about 3-4M shares....best thing that happened was going dark.....That really upset you....TO BAD you loser.

scottyb

scottyb 16 minutes ago

sure some big move

crynik

crynik 16 minutes ago

This already set a target high at .006's this year.........Production set to launch may 17th.......name change and ticker change coming also.........Its going back to at least .006's again folks........

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions